Biobank Sample Analysis Solutions
Comprehensive Genomic Solutions for Biobanks
Illumina helps maximize biobank specimen value by connecting the underlying genetics of your samples with the vast array of phenotypic information already associated with them. The combination of sequencing and microarray technologies facilitates a wide variety of biobank studies, ranging from biomarker and drug target identification to translational research, disease association studies, pharmacogenomics research, and more.
Illumina provides a comprehensive genomic solution for biobank sample analysis, with a seamless transition from variant discovery using next-generation sequencing (NGS) to the statistical power of large-scale genotyping with arrays. Whether you need standard microarrays, custom microarrays, or sequencing products, Illumina offers content flexibility for any application.
Propelling Progress with Microarrays
Dr. Weiss discusses how Illumina microarrays offer the quality and accuracy needed to fuel advances in biobank genotyping studies.
Arrays for Biobank Sample Analysis
Illumina microarrays deliver a robust way to genotype biobank samples from multiple different sources, including blood, saliva, and buccal swabs. Microarrays offer an efficient quality control method for specimens before storage or shipping. They also enable genome-wide association studies (GWAS) and phenome-wide association studies (PheWAS), which can be used to detect variants associated with disease or identify genomic targets for drug development.
Biobank Genotyping Arrays
Compare key specifications of Illumina arrays recommended for biobank genotyping studies.
Array Kit SelectorHuman Genotyping Arrays
Find whole-genome, exome, and targeted arrays featuring expert-defined content.
See All Array KitsCustom Genotyping Arrays
Design fully custom genotyping arrays targeting up to 1 million markers, or customize existing arrays with newly discovered markers.
Find Custom ArraysMethylation Analysis with Arrays
Quantitatively interrogate methylation sites across the genome at single-nucleotide resolution.
Learn MoreSequencing Biobank Samples
NGS offers an unbiased method to detect very rare variants which are difficult to identify using array technology. Whole-genome or whole-exome sequencing can be used to discover new SNPs and indels to include on future genotyping arrays, while targeted resequencing enables confirmation of array results and closer investigation of genomic regions of interest. RNA sequencing enables researchers to assess how variants affect transcription and gene expression.
The high resolution of sequencing complements the high throughput of arrays, providing a comprehensive view of the genome.
Learn more about:
Adding Novel Variants to Biobank Arrays
When sequencing of biobank samples reveals new causal variants, researchers need to validate these results on a larger scale. Custom genotyping arrays offer statistical power for screening these novel variants, either through addition of these markers to existing arrays, or through the design of fully custom arrays. Learn more about custom genotyping.
Biobank Solutions Brochure
Learn how Illumina sequencing and arrays work together to maximize the value of your specimens. Download Brochure.
Pharmacogenomics and Cardiovascular Disease
See how researchers used an Illumina array to identify responder genotypes in a failed cholesterol drug trial. Read Interview.
Related Solutions
Complex Disease Research
NGS and microarrays deliver the throughput, accuracy, and versatility needed for assessing the diverse aspects of complex disease biology. Learn more about complex disease genomics.
Translational Genomics Research
Our comprehensive NGS and array-based solutions can help researchers understand the role of genetics in disease identification, pathology, prognosis, treatment, and prevention. Learn more about translational research.
Cancer Research
Illumina technologies support multiple cancer research applications, and can enable a deeper and more accurate analysis of a tumor’s molecular profile. Learn more about cancer genomics.
Drug Development
Illumina offers genomic sequencing solutions to inform the drug development process, from discovery through companion diagnostics research. Learn more about NGS for drug development.
Microbial Epidemiology
NGS allows highly accurate, hypothesis-free analysis of pathogens. Examine variations across genomes to better understand the mechanisms that lead to infection and spread. Learn more about epidemiology.
Interested in receiving newsletters, case studies, and information on Biobank Sample Analysis Solutions? Enter your email address.
Additional Resources
Finding Disease-Related Genes from Biobank Data
Learn how the HUNT biobank leveraged Illumina microarrays to identify a gene that protects against heart attacks.
Study FFPE RNA
Analyze RNA isolated from FFPE tissues for cancer and genetic disease research.
Whole-Genome Genotyping
Find array and sequencing solutions for SNP genotyping, structural variation analysis, and genome-wide association studies (GWAS).
Targeted Genotyping
Access a variety of disease-specific and population-specific array solutions.
The Power of Population-Scale Genomics
Illumina technology is revolutionizing the study of population diversity.